| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/22/2004 | WO2003078649A3 Methods to increase nucleotide signals by raman scattering |
| 04/22/2004 | WO2003076937A9 Apparatus and methods for analyte measurement and immunoassay |
| 04/22/2004 | WO2003075751A3 Overfeeding methods for determining therapeutic strategies and/or targets for obesity therapeutics |
| 04/22/2004 | WO2003072106A3 Use of tyrosine kinase inhibitors for treating substance use disorders |
| 04/22/2004 | WO2003072014B1 Minicell compositions and methods |
| 04/22/2004 | WO2003062785A3 Detection of bovine viral diarrhea virus in hair samples |
| 04/22/2004 | WO2003062784A3 Apparatus and methods for monitoring the status of a metabolically active cell |
| 04/22/2004 | WO2003062471A9 Model cell systems for screening of anti-hypertrophic therapeutics |
| 04/22/2004 | WO2003061563A3 Method of preparing delta-9 tetrahydrocannabinol |
| 04/22/2004 | WO2003061561A8 Epsilon immunoglobulin chain derived peptides for induction of anti-ige antibodies |
| 04/22/2004 | WO2003060490A8 Measuring head for a gas analyser |
| 04/22/2004 | WO2003057916A3 Cancer profiles |
| 04/22/2004 | WO2003055994A9 Hxhv virus, nucleic material, peptide material and uses |
| 04/22/2004 | WO2003054482A3 An on-line oil condition sensor system for rotating and reciprocating machinery |
| 04/22/2004 | WO2003048720A3 Computer system and method for calculating adme properties |
| 04/22/2004 | WO2003046565A3 Ig lambda biopolymer markers predictive of alzheimers disease |
| 04/22/2004 | WO2003040721A8 Device and method for microchip based enzyme linked immunosorbent assay (elisa) |
| 04/22/2004 | WO2003038130A8 Therapeutics and diagnostics for disorders of erythropoiesis |
| 04/22/2004 | WO2003036337A3 Optical biological disk analyser |
| 04/22/2004 | WO2003035897A3 Enzyme substrates for detecting beta-d-ribofuranosidase activity |
| 04/22/2004 | WO2003035896A3 Chromogenic enzyme substrates and method for detecting beta-d-ribofuranosidase activity |
| 04/22/2004 | WO2003033738A3 Polymorphic marker that can be used to assess the efficacy of interferon therapy |
| 04/22/2004 | WO2003031985A3 Method for identification of modulators of pre-adipocyte differentiation |
| 04/22/2004 | WO2003031904A3 Non-contact sheet sensing system and related method |
| 04/22/2004 | WO2003029428A8 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease |
| 04/22/2004 | WO2003020763A9 Soluble t cell receptor |
| 04/22/2004 | WO2003014308A9 Cysteine mutants and methods for detecting ligand binding to biological molecules |
| 04/22/2004 | WO2002102846A3 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 04/22/2004 | WO2002102842A8 Immunogenic helicobacter surface proteins and their use |
| 04/22/2004 | WO2002100897A3 Brca1/acc alpha molecular complexes, diagnostic and therapeutic applications |
| 04/22/2004 | WO2002092782A3 Diagnosis and treatment of malignant neoplasms |
| 04/22/2004 | WO2002092017A8 Human antipneumococcal antibodies from non-human animals |
| 04/22/2004 | WO2002090577A3 Positive response biosensors and other sensors |
| 04/22/2004 | WO2002090567A3 Sperm-specific cation channel, and uses therefor |
| 04/22/2004 | WO2002074438A8 Structural units that define fluidic functions |
| 04/22/2004 | WO2002064731A9 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 04/22/2004 | WO2002057774B1 Detection of trace levels of water |
| 04/22/2004 | WO2002022858A9 Id-1 and id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma |
| 04/22/2004 | WO2002022803A9 Peptide epitopes recognized by antigen specific cd4+ t lymphocytes |
| 04/22/2004 | WO1990005910A3 Wholly microfabricated biosensors and process for the manufacture and use thereof |
| 04/22/2004 | US20040078851 Production of human growth factors in monocot seeds |
| 04/22/2004 | US20040078835 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 04/22/2004 | US20040078834 Transgenic animal whose genome has a transcriptional regulatory sequence capable of directing expression to b-cells linked to a dna sequence encoding t-cell leukemias |
| 04/22/2004 | US20040078833 Mutations in and genomic structure of herg - along QT syndrome gene |
| 04/22/2004 | US20040078149 Method of reducing analysis time of endpoint-type reaction profiles |
| 04/22/2004 | US20040078148 Site-directed mutagenesis; green fluorescent proteins; fusion proteins |
| 04/22/2004 | US20040077965 Measuring ammonia in expiration of individual using ammonia sensitive sensor having sensitivity to ammonia of 50-5000 ppb, comparing measure of basal ammonia against normative H. pylori positive population measure; optical sensor |
| 04/22/2004 | US20040077847 Nucleic acid encoding a pneumoccocal surface protein c gene or epitope |
| 04/22/2004 | US20040077841 Probes for identifying cancer-specific antigens |
| 04/22/2004 | US20040077840 Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroups B epitopes |
| 04/22/2004 | US20040077837 Microtubule-associated proteins and tubulins |
| 04/22/2004 | US20040077833 Regulation of human mrp5-like protein |
| 04/22/2004 | US20040077832 Jfy1protein induces rapid apoptosis |
| 04/22/2004 | US20040077831 Methods for removing analytes such as proteins, from biological compositions such as blood; blood cells prepared in this manner remain viable following prolonged storage and are suitable for therapeutic use e.g. in transfusion applications |
| 04/22/2004 | US20040077828 Proteins containing the motif that are capable of binding to secreted Frizzled-related protein (Sfrp) family members |
| 04/22/2004 | US20040077826 Randomly generated glycopeptide combinatorial libraries |
| 04/22/2004 | US20040077613 Stimulation of preadipocyte differentiation; insulin resis-tance syndrome, dyslipidemia, type 2 diabetes; LXR alpha receptor agonists |
| 04/22/2004 | US20040077591 Ameliorating physical disability in animal models; preserva-tion of body weight, reduced atrophy and weakness, extended survival |
| 04/22/2004 | US20040077581 Long chain fatty acid coA synthetase activity; polynucleotide encoding amino acid sequence 2 |
| 04/22/2004 | US20040077566 Methods and compositions for the treatment and diagnosis of body weight disorders |
| 04/22/2004 | US20040077536 Human and rat pgc-3, ppar-gamma coactivations and splice variants thereof |
| 04/22/2004 | US20040077535 Novel physiologically active peptide and use thereof |
| 04/22/2004 | US20040077532 Aglyco products and methods of use |
| 04/22/2004 | US20040077106 Synthetic urine and method of making same |
| 04/22/2004 | US20040077104 Includes a substrate micro-fabricated to define a mesoscale flow system for detecting the presence of an antigen in a fluid sample |
| 04/22/2004 | US20040077103 Diagnostic devices and apparatus for the controlled movement of reagents without membranes |
| 04/22/2004 | US20040077100 Fluorescence polarization assay |
| 04/22/2004 | US20040077097 Reagent and test cartridge for determining clotting time |
| 04/22/2004 | US20040077096 Materials on a fluid permeable support contained within a reaction cell having a semipermeable membrane rapidly screened for characteristics such as catalytic activity, selectivity, and adsorption and desorption properties |
| 04/22/2004 | US20040077092 Control and calibration material for blood coagulation tests |
| 04/22/2004 | US20040077091 A stimulus is provided to each member of the library, a response of each of the material samples due to the stimulus is measured and the response, the stimulus or both are recorded and related to provided data |
| 04/22/2004 | US20040077090 Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating |
| 04/22/2004 | US20040077080 Compositions and methods for induction of proteins involved in xenobiotic metabolism |
| 04/22/2004 | US20040077079 Methods, kits and production plant for use in the production of cell colony forming units from a mammalian tissue explant and to the use of cells from such cell colony forming units in treatment of mammals suffering from tissue disorders |
| 04/22/2004 | US20040077066 Purified active HCV NS2/3 protease |
| 04/22/2004 | US20040077064 Identification and isolation of novel DNA and to the recombinant production of novel polypeptides |
| 04/22/2004 | US20040077053 Methods to identify growth differentiation factor (GDF) receptors |
| 04/22/2004 | US20040077051 LSR receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications |
| 04/22/2004 | US20040077049 For preventing, ameliorating, disorders or diseases including cancer, peripheral and central nervous system disorders, genitourinary disorders, cardiovascular disorders, and Chronic obstructive pulmonary (or airways) disease (COPD) |
| 04/22/2004 | US20040077046 Histone deacetylase-related gene and protein |
| 04/22/2004 | US20040077031 Using the manganese form of the enzyme and therefore, the advantage of identifying potent inhibitors that might not show activity in cellular systems because the wrong metal cofactor is used |
| 04/22/2004 | US20040077028 Assay for thrombocytopenia associated with administration of platelet GPIIb-IIIa receptor antagonists |
| 04/22/2004 | US20040077027 Detecting an increased risk of heart failure in a subject by detecting an increased level of urotensin II in a bodily fluid sample from a subject |
| 04/22/2004 | US20040077026 Rapid evaluation of the ratio of biological molecules |
| 04/22/2004 | US20040077025 Cripto-1 (CR-1) is a member of Epidermal Growth Factors ; comprising exposing a fluid sample to an antibody under conditions such that the Cripto-1 and antibody bind to form an antigen-antibody complex which is detected and measured |
| 04/22/2004 | US20040077024 Method of reversibly disrupting a conjugate comprising a biotin compound and a biotin compound |
| 04/22/2004 | US20040077023 By measuring levels of antibodies to glycans in a biological sample |
| 04/22/2004 | US20040077021 Haptens, intermediates, and immunogens that are useful in the production of antibodies specific for the methylenedioxy class of amphetamine derivatives |
| 04/22/2004 | US20040077020 Diagnostic microarray for inflammatory bowel disease, crohn's disease and ulcerative colitis |
| 04/22/2004 | US20040077019 Tagging compounds and process for use in aida libraries |
| 04/22/2004 | US20040077017 Detection methods |
| 04/22/2004 | US20040077014 Kit for enhancing the association rates of polynucleotides |
| 04/22/2004 | US20040077001 Use for carboxypeptidase-A4 in the diagnosis and treatment of metabolic disorders |
| 04/22/2004 | US20040077000 Using cynomologous monkey P-glycoprotein nucleic acids and polypeptides in determining bioavailability of drugs and for screening for inhibitors of cynomologous P-glycoprotein |
| 04/22/2004 | US20040076999 Computer user interface facilitating acquiring and analyzing of biological specimen traits |
| 04/22/2004 | US20040076998 Sequencing method using magnifying tags |
| 04/22/2004 | US20040076997 Determining the risk of metastasis of a breast or colon tumor, which involve determining whether a tissue sample from a tumor expresses a polypeptide encoded by a gene SEQ ID NOS:1-18 |
| 04/22/2004 | US20040076994 Method of detecting target nucleic acid and nucleic acid probe |
| 04/22/2004 | US20040076992 Novel cell adhesion molecule specific to activated leukocyte |
| 04/22/2004 | US20040076989 A method for assaying the ability of a test compound to induce or modulate immediate-early or other reporter gene transcription and/or translation |